Rocket Lab (NASDAQ:RKLB) Shares Down 6.6% – Time to Sell?

Rocket Lab Corporation (NASDAQ:RKLB)’s share price fell 6.6% on Thursday. The stock traded as low as $49.69 and last traded at $55.25. Approximately 47,868,544 shares changed hands during mid-day trading, an increase of 107% from the average session volume of 23,094,160 shares. The stock had previously closed at $59.18.

Key Rocket Lab News

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab retains approximately $2.4 billion in backlog, alongside its established Electron launch business, satellite systems operations and defense-related contracts. Analysts argue these businesses provide support while Neutron development continues. Rocket Lab Still Has a $2.4B Backlog While Neutron Waits
• Positive Sentiment: Some analysts remain constructive: TD Cowen reaffirmed a Buy rating with a $90 price target, while Roth Capital maintained Buy at $110. Cantor Fitzgerald also maintained its rating with a $122 target, suggesting substantial long-term upside if execution improves. Stay Cool, Says Analyst About Rocket Lab Stock
• Neutral Sentiment: Rocket Lab said Neutron’s first launch is now expected in 2027 rather than late 2026. The company plans to complete additional testing in the first quarter before setting a specific launch date, making the timing uncertain but allowing more time to address reliability issues. Rocket Lab Provides Update on Neutron Development and Adjusts Target Launch Timing
• Negative Sentiment: The delay was triggered by a manufacturing flaw in a carbon-composite propellant tank dome on Neutron’s first stage. The issue follows a tank rupture during testing in January, raising concerns about development execution, additional costs and the company’s ability to compete with SpaceX in medium-lift launches. Rocket Lab pushes Neutron rocket’s debut flight to 2027
• Negative Sentiment: KeyBanc reduced its price target to $100, and Clear Street set a $105 target, reflecting heightened execution risk. Investors are also weighing recent equity issuance for the planned Iridium acquisition, insider selling and lower projected gross margins, which could increase dilution and cash-burn concerns.
• Negative Sentiment: A broader selloff in technology and semiconductor stocks contributed to risk-off sentiment, but the Neutron setback was the primary company-specific catalyst behind RKLB’s decline.

Analysts Set New Price Targets

A number of research firms have issued reports on RKLB. KeyCorp reduced their target price on shares of Rocket Lab from $135.00 to $100.00 and set an “overweight” rating on the stock in a report on Thursday. Needham & Company LLC reaffirmed a “buy” rating on shares of Rocket Lab in a report on Tuesday, August 11th. TD Cowen reissued a “buy” rating and issued a $90.00 price objective on shares of Rocket Lab in a report on Thursday. Morgan Stanley restated an “overweight” rating on shares of Rocket Lab in a research report on Wednesday, July 8th. Finally, Craig Hallum increased their price target on Rocket Lab from $98.00 to $120.00 and gave the stock a “buy” rating in a report on Monday, June 29th. Four analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Rocket Lab presently has a consensus rating of “Moderate Buy” and a consensus target price of $104.05.

Rocket Lab Trading Down 6.6%

The company has a market capitalization of $33.06 billion, a PE ratio of -204.62 and a beta of 2.93. The business has a fifty day moving average price of $69.91 and a 200 day moving average price of $84.33. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48.

Rocket Lab (NASDAQ:RKLB) last posted its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The company had revenue of $234.07 million during the quarter, compared to analyst estimates of $231.62 million. Analysts expect that Rocket Lab Corporation will post -0.20 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, insider Frank Klein sold 45,692 shares of the firm’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $3,181,533.96. Following the transaction, the insider directly owned 961,295 shares of the company’s stock, valued at approximately $66,934,970.85. This trade represents a 4.54% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Arjun Kampani sold 7,754 shares of the firm’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $539,911.02. Following the completion of the sale, the senior vice president owned 256,951 shares of the company’s stock, valued at $17,891,498.13. This represents a 2.93% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 400,749 shares of company stock worth $26,964,474 over the last three months. Company insiders own 8.40% of the company’s stock.

Institutional Investors Weigh In On Rocket Lab

Large investors have recently modified their holdings of the business. Assenagon Asset Management S.A. boosted its stake in shares of Rocket Lab by 24.2% during the 3rd quarter. Assenagon Asset Management S.A. now owns 21,831 shares of the rocket manufacturer’s stock worth $1,521,000 after buying an additional 4,251 shares during the last quarter. Formuepleje A S bought a new position in Rocket Lab in the 3rd quarter valued at about $425,000. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in Rocket Lab during the third quarter worth about $446,000. HBW Advisory Services LLC increased its stake in shares of Rocket Lab by 2.4% in the third quarter. HBW Advisory Services LLC now owns 7,816 shares of the rocket manufacturer’s stock valued at $545,000 after buying an additional 182 shares during the period. Finally, Tempus Wealth Planning LLC raised its holdings in Rocket Lab by 3.0% during the 3rd quarter. Tempus Wealth Planning LLC now owns 26,402 shares of the rocket manufacturer’s stock worth $1,840,000 after purchasing an additional 768 shares during the last quarter. 71.78% of the stock is currently owned by institutional investors.

About Rocket Lab

Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.

Rocket Lab’s primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.